Efficacy and Safety Study of Sorafenib Plus Pravastatin to Treat Advanced Hepatocarcinoma
Status:
Completed
Trial end date:
2017-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the overall survival (OS) in order to assess the
efficacy and safety of pravastatin as adjuvant treatment to sorafenib.